10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,913,537 | +59.6% | 88,072 | +4.3% | 0.43% | +74.4% |
Q4 2022 | $3,078,305 | +68.7% | 84,476 | +31.9% | 0.25% | +58.7% |
Q3 2022 | $1,825,000 | -46.7% | 64,064 | -15.3% | 0.16% | -46.6% |
Q2 2022 | $3,421,000 | -44.0% | 75,594 | -5.8% | 0.29% | -39.5% |
Q1 2022 | $6,107,000 | -73.7% | 80,276 | -48.5% | 0.48% | -67.7% |
Q4 2021 | $23,231,000 | +11.8% | 155,952 | +9.2% | 1.48% | +14.9% |
Q3 2021 | $20,784,000 | +3.1% | 142,772 | +38.7% | 1.29% | +26.3% |
Q2 2021 | $20,153,000 | +12.4% | 102,914 | +3.9% | 1.02% | -14.1% |
Q1 2021 | $17,930,000 | – | 99,061 | – | 1.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |